Cargando…
CpG Island Methylation in Colorectal Cancer: Past, Present and Future
The concept of a CpG island methylator phenotype, or CIMP, quickly became the focus of several colorectal cancer studies describing its clinical and pathological features after its introduction in 1999 by Toyota and colleagues. Further characterization of CIMP in tumors lead to widespread acceptance...
Autores principales: | Curtin, Karen, Slattery, Martha L., Samowitz, Wade S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090226/ https://www.ncbi.nlm.nih.gov/pubmed/21559209 http://dx.doi.org/10.4061/2011/902674 |
Ejemplares similares
-
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015) -
The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013) -
Deoxyribonucleic acid methylation profiling of single human blastocysts by methylated CpG-island amplification coupled with CpG-island microarray
por: Huntriss, John, et al.
Publicado: (2015) -
Prognostic Significance of CpG Island Methylator Phenotype in Colorectal Cancer
por: Joo, Young-Eun
Publicado: (2015)